Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
University of Texas at Austin · with Texas Alzheimer's Research and Care Consortium · NCT05907343
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 180
- US sites recruiting
- 1
- Study start
- May 31, 2023
- Record last updated
- September 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in older adults with and without cognitive impairment. The main questions it aims to answer are:
- whether it is possible to restore various cognitive functions in older adults by delivering theta burst stimulation (TBS), a form of transcranial magnetic stimulation, and
- whether closed-loop TBS is able to induce therapeutic benefits that outperform open-loop TBS.
Participants play a cognitive video game while a brain-computer interface (BCI) analyzes their electroencephalogram (EEG) signals and decodes the presence or absence of the contingent negative variation (CNV) potential, a marker of cognitive control. The BCI triggers TBS when its outputs indicate that the participant is not engaged properly in the video game.
Researchers will compare the effects of closed-loop and open-loop TBS using the outcome metrics described below to see how much cognitive restorations is achievable with each stimulation modality.
Being studied: Closed-loop TBS; Open-loop TBS
Conditions: Mild Cognitive Impairment; Alzheimer Dementia (AD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Older adults
- Ages between 60 to 90 years
- Good general health
- Normal or corrected vision
- Completed elementary school education or able to understand middle school level experiment instructions
- Self reports cognitive complaints
- Cognitively normal young adults
- Ages between 18 to 35 years
- Good general health
- Normal or corrected vision
- Completed elementary school education or able to understand middle school level experiment instructions
Exclusion Criteria
- Self-report of neurological or psychiatric diseases that could be contraindicated for TMS (e.g., personal history of epilepsy/seizure brain damage, history of fainting, bipolar disorder, schizophrenia, current substance use disorder, etc.).
- Medications that elevate seizure threshold (e.g., stimulant medication, high dose bupropion).
- Factors hindering EEG acquisition and rTMS delivery (e.g., skin infection, wounds, dermatitis, unable to access the scalp of the participant (e.g., unremovable wig).
- Current participation in amyloid infusion treatment for Alzheimer's disease.
- Do not have the capacity to provide informed consent and does not have a Legally Authorized Representative.
- Resting motor threshold below the power limit in the laboratory. (Will be check on the first visit)
Recruiting US locations
Health Discovery Building
Austin, TX 78712
Site contact: Patrick Escamilla · 512-495-5246 · pescamilla@austin.utexas.edu
Study contacts (from the official record)
- José del R. Millán, PhD · 512-232-8111 · jose.millan@austin.utexas.edu
- Minsu Zhang · 512-840-9310 · minsuzhang@austin.utexas.edu
Similar studies in Texas
All neurology studies in Texas →- RecruitingHealthy volunteersPhase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Eli Lilly and Company
- Location
- Austin, TX + 7 other US sites
- Eligibility basics
- Ages 30–85
- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Cypress, TX + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 1Overnight stay mentioned
MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.
- Location
- Fredericksburg, TX
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersEarly Phase 1
Pharmacological Modulation of Brain Oscillations in Memory Processing
University of Texas Southwestern Medical Center
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–55